Literature DB >> 30684005

[Work sampling in ophthalmological clinical studies. A multicenter field study].

D Böhringer1, D Goos2, T Ach3, N Feltgen4, M Fleckenstein5, T Kohnen6, K Lorenz7, A Pielen8, G Spital9, B Wilhelm10, S Böhringer11, T Reinhard1.   

Abstract

BACKGROUND: Work in clinical studies is generally more elaborate and therefore more time-consuming in comparison to the clinical routine. The purpose of this study was to systematically investigate the time consumption in the German ophthalmological clinical trial centers.
METHODS: The members of the working group of the German Ophthalmology Society clinical study centers (Arbeitsgemeinschaft DOG Klinische Studienzentren) were asked to fill in three questionnaires about best estimations for the time spent on study-related procedures and administration. Additionally, work sampling was performed for each employee at each study center over a period of 3 weeks.
RESULTS: The questionnaires were completed by 9 of the 11 centers. Overall, 5504 working hours were recorded. On an average working day, the time spent for both documentation and administration averaged 4 h each. Operative interventions consumed a significant amount of time (2.8 h), as did ophthalmological examinations (2.5 h) and obtaining informed consent (1.5 h). The recorded time consumption for visual acuity testing, informed consent and documentation was well aligned with the best estimates of the three questionnaires. By contrast, interventions, ophthalmological examinations and biomaterial sample handling were underrated in the best estimations. DISCUSSION: A considerable amount of time in clinical studies is spent on documentation and administration. From work sampling, ophthalmological examinations and biomaterial sampling turned out to be surprisingly time consuming. This is probably due to preparation and postprocessing tasks. It is important to consider this when calculating the overall costs of a clinical study. In addition, many administrative activities cannot be attributed to specific patients and can therefore not be compensated on the basis of case payments alone. Additional remuneration is required to fully cover the costs in an ophthalmological study center.

Entities:  

Keywords:  Clinical studies; Cost calculation; Documentation; Time survey; Work sampling

Mesh:

Year:  2019        PMID: 30684005     DOI: 10.1007/s00347-019-0851-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  7 in total

Review 1.  Good clinical practice: a nuisance, a help or a necessity for clinical pharmacology?

Authors:  John Sweatman
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

2.  Measurement and analysis of visual acuity in multicenter randomized clinical trials in the United States: findings from a survey.

Authors:  Li Ming Dong; Marta J Marsh; Barbara S Hawkins
Journal:  Ophthalmic Epidemiol       Date:  2003-07       Impact factor: 1.648

3.  [Clinical research in ophthalmology: Medical prerequisites].

Authors:  D Goos; Daniel Böhringer
Journal:  Ophthalmologe       Date:  2015-06       Impact factor: 1.059

4. 

Authors: 
Journal:  Klin Monbl Augenheilkd       Date:  2018-07-06       Impact factor: 0.700

Review 5.  A systematic review of on-site monitoring methods for health-care randomised controlled trials.

Authors:  Rhiannon C Macefield; Andrew D Beswick; Jane M Blazeby; J Athene Lane
Journal:  Clin Trials       Date:  2013-02       Impact factor: 2.486

6.  Work-Time Distribution of Physicians at a German University Hospital.

Authors:  Jan Wolff; Gerd Auber; Tobias Schober; Felix Schwär; Karl Hoffmann; Marc Metzger; Andrea Heinzmann; Marcus Krüger; Claus Normann; Gerald Gitsch; Norbert Südkamp; Thomas Reinhard; Mathias Berger
Journal:  Dtsch Arztebl Int       Date:  2017-10-20       Impact factor: 5.594

7.  Successful recruitment to trials: findings from the SCIMITAR+ Trial.

Authors:  Emily Peckham; Catherine Arundel; Della Bailey; Tracy Callen; Christina Cusack; Suzanne Crosland; Penny Foster; Hannah Herlihy; James Hope; Suzy Ker; Tayla McCloud; Crystal-Bella Romain-Hooper; Alison Stribling; Peter Phiri; Ellen Tait; Simon Gilbody
Journal:  Trials       Date:  2018-01-19       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.